FindTrial
Sign In

LINX Reflux Management System

DEVICE3 trials

Sponsors

Torax Medical Incorporated, Ethicon Endo-Surgery, Foregut Research Foundation

Conditions

GERD Gastroesophageal Reflux DiseaseGastro Esophageal RefluxGastroesophageal RefluxHiatal HerniaHiatal Hernia LargeHiatal Hernia, ParaesophagealReflux AcidReflux, Gastroesophageal

Phase 4

The CALIBER Study Randomized Controlled Trial of LINX Versus Double-Dose Proton Pump Inhibitor Therapy for Reflux Disease
CompletedNCT02505945
Torax Medical IncorporatedGERD Gastroesophageal Reflux Disease
Start: 2015-06-30End: 2018-08-31Updated: 2019-01-07

Unknown Phase

RETHINK REFLUX Registry
Active, not recruitingNCT04253392
Ethicon Endo-SurgeryGastroesophageal Reflux
Start: 2020-07-08End: 2032-07-31Updated: 2026-08-28
LINX Reflux Management System or Fundoplication Clinical Study in Patients With Hiatal Hernia >3 cm
TerminatedNCT04695171
Foregut Research FoundationGastro Esophageal Reflux, Hiatal Hernia, Hiatal Hernia Large +3
Start: 2021-01-14End: 2026-01-14Updated: 2026-02-09

Related Papers

Number of reflux episodes on pH-impedance monitoring associates with improved symptom outcome and treatment satisfaction in gastro-oesophageal reflux disease (GERD) patients with regurgitation
Gut2020-05-2846 citations
Covid-19: NHS will restart some paused services this week
BMJ2020-04-284 citations
Magnetic Sphincter Augmentation Superior to Proton Pump Inhibitors for Regurgitation in a 1-Year Randomized Trial
Clinical Gastroenterology and Hepatology2019-09-1062 citations
Laparoscopic magnetic sphincter augmentation versus double-dose proton pump inhibitors for management of moderate-to-severe regurgitation in GERD: a randomized controlled trial.
2018-07-1868 citations